[Comprehensive strategy for retinal neuroprotection. Challenging the clinical application].

Medicine and Dentistry

• Photoreceptor 100%
• Membrane 50%
• Retinal Disease 50%
• Programmed Cell Death 33%
• Brilliant Blue 33%
• Retina 33%
• Apoptosis Inducing Factor 33%
• Transcription Factor RUNX2 25%
• Death 25%
• Neuroprotective Agent 25%
• Oxygen Saturation 25%
• Cells 16%
• Combination Therapy 16%
• Therapeutic Procedure 16%
• Tissues 16%
• Analysis 16%
• Vision 16%
• Surgical Stress 16%
• Retinal Detachment 16%
• Pigment Epithelium Derived Factor 16%
• Retina Disease 16%
• Retinal Examination 16%
• Patient 8%
• Gene Expression Profiling 8%
• Clinical Trial 8%
• Diseases 8%
• Amaurosis 8%
• Morphology 8%
• Adenosine Triphosphate 8%
• Gene Therapy 8%
• Vitrectomy 8%
• Epiretinal Membrane 8%
• Visual Acuity 8%
• Cell Membrane 8%
• Binocular Convergence 8%
• Eye Disease 8%
• Diabetic Retinopathy 8%
• Spectroscopy 8%
• Smooth Muscle Actin 8%
• Retinitis pigmentosa 8%
• Antagonist 8%
• Ganglion 8%
• Dye 8%
• Visual Impairment 8%
• Eye Surgery 8%

Neuroscience

• Neuroprotection 75%
• Apoptosis-Inducing Factor 33%
• Neuroprotective Agent 25%
• Oxygen Saturation 25%
• Transcription Factor RUNX2 25%
• Apoptosis 16%
• Retinal Detachment 16%
• Pigment Epithelium Derived Factor 16%
• P2RX7 16%
• Gene 8%
• Gene Expression 8%
• Retinal Ganglion Cell 8%
• Adenosine Triphosphate 8%
• Cell Membrane 8%
• Vision 8%
• Ophthalmic Disorder 8%
• Diabetic Retinopathy 8%
• Retinitis pigmentosa 8%
• Smooth Muscle Actin 8%
• Epiretinal Membrane 8%